Maria L. Cornellier

Maria L. Cornellier

Auto-generated profile, based on publicly available information

Maria L. Cornellier

University of Michigan Health System, Ann Arbor, US

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Circulation: Heart Failure
Verified
Journal Article
Closed access
SHScott L. Hummel
Scott L. Hummel
WKWahida Karmally
Wahida Karmally
BGBrenda W. Gillespie
Brenda W. Gillespie
SHStephen Helmke
Stephen Helmke
STSergio Teruya
Sergio Teruya
MMMathew S. Maurer
Mathew S. Maurer
Background: In patients with heart failure (HF), malnutrition and dietary sodium excess are common and may worsen outcomes. No prior studies have provided low-sodium, nutritionally complete meals following HF hospitalization. Methods and Results: The GOURMET-HF study (Geriatric Out-of-Hospital Randomized Meal Trial in Heart Failure) randomized patients discharged from HF hospitalization to 4 weeks of home-delivered sodium-restricted Dietary Approaches to Stop Hypertension meals (DASH/SRD; 1500 mg sodium/d) versus usual care. The primary outcome was the between-group change in the Kansas City Cardiomyopathy Questionnaire summary score from discharge to 4 weeks postdischarge. Additional outcomes included changes in the Kansas City Cardiomyopathy Questionnaire clinical summary score and cardiac biomarkers. All patients were followed 12 weeks for death/all-cause readmission and potential diet-related adverse events (symptomatic hypotension, hyperkalemia, acute kidney injury). Sixty-six patients were randomized 1:1 at discharge to DASH/SRD versus usual care (age, 71±8 years; 30% female; ejection fraction, 39±18%). The Kansas City Cardiomyopathy Questionnaire summary score increased similarly between groups (DASH/SRD 46±23–59±20 versus usual care 43±19–53±24; P =0.38), but the Kansas City Cardiomyopathy Questionnaire clinical summary score increase tended to be greater in DASH/SRD participants (47±22–65±19 versus 45±20–55±26; P =0.053). Potentially diet-related adverse events were uncommon; 30-day HF readmissions (11% versus 27%; P =0.06) and days rehospitalized within that timeframe (17 versus 55; P =0.055) trended lower in DASH/SRD participants. Conclusions: Home-delivered DASH/SRD after HF hospitalization appeared safe in selected patients and had directionally favorable effects on HF clinical status and 30-day readmissions. Larger studies are warranted to clarify the effects of postdischarge nutritional support in patients with HF. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02148679.

2 December 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
SZSuzanna Maria Zick
Suzanna Maria Zick
Justin A. ColacinoJustin A. Colacino
Justin A. Colacino
MCMaria Cornellier
Maria Cornellier
TKTohfa Khabir
Tohfa Khabir
KSKatie Surnow
Katie Surnow
ZDZora Djuric
Zora Djuric

10 August 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MDMichael P Dorsch
Michael P Dorsch
MCMaria L Cornellier
Maria L Cornellier
APArmella D Poggi
Armella D Poggi
FBFeriha Bilgen
Feriha Bilgen
PCPeiyu Chen
Peiyu Chen
SHScott L Hummel
Scott L Hummel
Background: High dietary sodium intake is a significant public health problem in the United States. High sodium consumption is associated with high blood pressure and high risk of cardiovascular disease. Objective: The aim of this study was to evaluate the effect of a just-in-time adaptive mobile app intervention, namely, LowSalt4Life, on reducing sodium intake in adults with hypertension. Methods: In this study, 50 participants aged ≥18 years who were under treatment for hypertension were randomized (1:1, stratified by gender) into 2 groups, namely, the App group (LowSalt4Life intervention) and the No App group (usual dietary advice) in a single-center, prospective, open-label randomized controlled trial for 8 weeks. The primary endpoint was the change in the 24-hour urinary sodium excretion estimated from spot urine by using the Kawasaki equation, which was analyzed using unpaired two-sided t tests. Secondary outcomes included the change in the sodium intake measured by the food frequency questionnaire (FFQ), the 24-hour urinary sodium excretion, blood pressure levels, and the self-reported confidence in following a low-sodium diet. Results: From baseline to week 8, there was a significant reduction in the Kawasaki-estimated 24-hour urinary sodium excretion calculated from spot urine in the App group compared to that in the No App group (–462 [SD 1220] mg vs 381 [SD 1460] mg, respectively; P=.03). The change in the 24-hour urinary sodium excretion was –637 (SD 1524) mg in the App group and –322 (SD 1485) mg in the No App group (P=.47). The changes in the estimated sodium intake as measured by 24-hour dietary recall and by FFQ in the App group were –1537 (SD 2693) mg and –1553 (SD 1764) mg while those in the No App group were –233 (SD 2150) mg and –515 (SD 1081) mg, respectively (P=.07 and P=.01, respectively). The systolic blood pressure change from baseline to week 8 in the App group was –7.5 mmHg while that in the No App group was –0.7 mmHg (P=.12), but the self-confidence in following a low-sodium diet was not significantly different between the 2 groups. Conclusions: This study shows that a contextual just-in-time mobile app intervention resulted in a greater reduction in the dietary sodium intake in adults with hypertension than that in the control group over a 8-week period, as measured by the estimated 24-hour urinary sodium excretion from spot urine and FFQ. The intervention group did not show a significant difference from the control group in the self-confidence in following a low sodium diet and in the 24-hour urinary sodium excretion or dietary intake of sodium as measured by the 24-hour dietary recall. A larger clinical trial is warranted to further elucidate the effects of the LowSalt4Life intervention on sodium intake and blood pressure levels in adults with hypertension. Trial Registration: ClinicalTrials.gov NCT03099343; https://clinicaltrials.gov/ct2/show/NCT03099343 International Registered Report Identifier (IRRID): RR2-10.2196/11282

20 September 2013 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
ESE. Sidahmed
E. Sidahmed
MCM. L. Cornellier
M. L. Cornellier
JRJ. Ren
J. Ren
LAL. M. Askew
L. M. Askew
YLY. Li
Y. Li
ZDZ. Djuric
Z. Djuric

1 September 2012 in Contemporary Clinical Trials
Verified
Journal Article
Open access
ZDZora Djuric
Zora Djuric
MRMack T. Ruffin
Mack T. Ruffin
MRMary E. Rapai
Mary E. Rapai
MCMaria L. Cornellier
Maria L. Cornellier
JRJianwei Ren
Jianwei Ren
DTD. Kim Turgeon
D. Kim Turgeon
This study recruited persons at increased risk of colon cancer to an intensive dietary intervention study that required biopsies of the colon by flexible sigmoidoscopy at baseline and after six months of intervention. A total of 1314 individuals contacted the study, and only 16 individuals indicated that the sigmoidoscopy procedure was an obstacle to study participation. A total of 270 individuals completed a screening visit and signed a screening consent form. Inquiries about the study tended to be fewer in the winter and late summer. Failure to return food records was the most common reason for exclusion. Dietary recall at enrollment indicated that subjects were consuming significantly more vegetables, lower sodium and a lower glycemic load on the day before starting the study vs. during the eligibility phase which might have an impact on biomarker measures. This makes it important to capture dietary changes in the period between determination of eligibility and enrollment. Subjects (n=120) were randomized to follow a Healthy Eating or a Mediterranean Diet, each of which required substantial dietary record-keeping. The study completion rate was 78%, and subjects reported high satisfaction with study participation. Of the 93 individuals who completed the study, only one refused the flexible sigmoidoscopy at the final visit. These findings suggest that flexible sigmoidoscopy does not appear to be a barrier for recruitment of high-risk individuals to an intensive dietary intervention trial, but that completing food records can be.

1 March 2017 in JACC
Verified
Journal Article
Closed access
SHScott L. Hummel
Scott L. Hummel
WKWahida Karamally
Wahida Karamally
OJOmar Jimenez
Omar Jimenez
MCMaria L. Cornellier
Maria L. Cornellier
ETErika Trumble
Erika Trumble
MMMathew Maurer
Mathew Maurer